Hepatitis C Stocks List

Recent Signals

Date Stock Signal Type
2019-10-17 BNTC NR7 Range Contraction
2019-10-17 BNTC Narrow Range Bar Range Contraction
2019-10-17 BNTC Shooting Star Candlestick Bearish
2019-10-17 ENTA Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-10-17 ENTA MACD Bullish Signal Line Cross Bullish
2019-10-17 ENTA 1,2,3 Retracement Bearish Bearish Swing Setup
2019-10-17 SCYX Crossed Above 50 DMA Bullish
2019-10-17 UTHR 20 DMA Support Bullish
2019-10-17 UTHR 50 DMA Support Bullish
2019-10-17 UTHR Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-10-17 XTLB Narrow Range Bar Range Contraction
2019-10-17 XTLB Fell Below 20 DMA Bearish
2019-10-17 XTLB MACD Bullish Signal Line Cross Bullish

Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver. During the initial infection people often have mild or no symptoms. Occasionally a fever, dark urine, abdominal pain, and yellow tinged skin occurs. The virus persists in the liver in about 75% to 85% of those initially infected. Early on chronic infection typically has no symptoms. Over many years however, it often leads to liver disease and occasionally cirrhosis. In some cases, those with cirrhosis will develop complications such as liver failure, liver cancer, or dilated blood vessels in the esophagus and stomach.HCV is spread primarily by blood-to-blood contact associated with intravenous drug use, poorly sterilized medical equipment, needlestick injuries in healthcare, and transfusions. Using blood screening, the risk from a transfusion is less than one per two million. It may also be spread from an infected mother to her baby during birth. It is not spread by superficial contact. It is one of five known hepatitis viruses: A, B, C, D, and E. Diagnosis is by blood testing to look for either antibodies to the virus or its RNA. Testing is recommended in all people who are at risk.There is no vaccine against hepatitis C. Prevention includes harm reduction efforts among people who use intravenous drugs and testing donated blood. Chronic infection can be cured about 95% of the time with antiviral medications such as sofosbuvir or simeprevir. Peginterferon and ribavirin were earlier generation treatments that had a cure rate of less than 50% and greater side effects. Getting access to the newer treatments however can be expensive. Those who develop cirrhosis or liver cancer may require a liver transplant. Hepatitis C is the leading reason for liver transplantation, though the virus usually recurs after transplantation.An estimated 143 million people (2%) worldwide are infected with hepatitis C as of 2015. In 2013 about 11 million new cases occurred. It occurs most commonly in Africa and Central and East Asia. About 167,000 deaths due to liver cancer and 326,000 deaths due to cirrhosis occurred in 2015 due to hepatitis C. The existence of hepatitis C – originally identifiable only as a type of non-A non-B hepatitis – was suggested in the 1970s and proven in 1989. Hepatitis C infects only humans and chimpanzees.

More about Hepatitis C